Lysozyme C Monoclonal Antibody (

Confirm delete?

Lysozyme C Monoclonal Antibody (Clone 4C3)

Zoom

Cat No: 15641

Lysozymes are a critical component of the innate immune system, facilitating the breakdown of bacterial cell walls by catalyzing the hydrolysis of peptidoglycan components. Lysozyme C is a component of many animal secretions such as saliva, tears, and...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

lysozymes granulocytes neutrophils immune systems bacterial cells breakdown walls catalyzing peptidoglycan C animals secretions saliva tears mucus rheumatoid arthritis systemic lupus extracellular traps NETs pathogens autoimmune diseases flow cytometry FC ELISA immunofluorescence antibodies IF innate clones 4C3 IgG3

Product Overview:
Lysozymes are a critical component of the innate immune system, facilitating the breakdown of bacterial cell walls by catalyzing the hydrolysis of peptidoglycan components. Lysozyme C is a component of many animal secretions such as saliva, tears, and mucus.{25779} Elevated serum levels of lysozymes have been associated with rheumatoid arthritis and systemic lupus.{25778} Lysozyme C is a component of neutrophil extracellular traps (NETs), which have the ability to contact and kill pathogens.{24590} Cayman’s Monoclonal Antibody detects lysozyme C in neutrophil-derived NETs.

Size	1 ea
Shipping	dry ice
Host	Mouse
Clone	4C3
Isotype	IgG3
Application(s)	FC and IF
Formulation	200 µg of ammonium sulfate-purified IgG3 in 200 µl PBS, pH 7.2, containing 50% glycerol, 0.5 mg/ml BSA, and 0.02% sodium azide
Custom Code	3822.19
UNSPSC code	12352203

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.